BR9911756A - Composto, uso de um secretagogo do hormÈnio do crescimento ou um seu sal farmaceuticamente aceitável, composição farmacêutica, método para estimular a liberação do hormÈnio do crescimento pela pituitária de um mamìfero, e, uso de um composto - Google Patents
Composto, uso de um secretagogo do hormÈnio do crescimento ou um seu sal farmaceuticamente aceitável, composição farmacêutica, método para estimular a liberação do hormÈnio do crescimento pela pituitária de um mamìfero, e, uso de um compostoInfo
- Publication number
- BR9911756A BR9911756A BR9911756-8A BR9911756A BR9911756A BR 9911756 A BR9911756 A BR 9911756A BR 9911756 A BR9911756 A BR 9911756A BR 9911756 A BR9911756 A BR 9911756A
- Authority
- BR
- Brazil
- Prior art keywords
- growth hormone
- compound
- pituitary
- release
- pharmaceutically acceptable
- Prior art date
Links
- 102000018997 Growth Hormone Human genes 0.000 title abstract 4
- 108010051696 Growth Hormone Proteins 0.000 title abstract 4
- 239000000122 growth hormone Substances 0.000 title abstract 4
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 230000001817 pituitary effect Effects 0.000 title abstract 2
- 150000003839 salts Chemical class 0.000 title abstract 2
- 102100033367 Appetite-regulating hormone Human genes 0.000 title 1
- 101710111255 Appetite-regulating hormone Proteins 0.000 title 1
- 241000124008 Mammalia Species 0.000 title 1
- 239000003324 growth hormone secretagogue Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 2
- 230000007812 deficiency Effects 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0207—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
- A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Abstract
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA199800857 | 1998-06-30 | ||
DKPA199801440 | 1998-11-09 | ||
PCT/DK1999/000368 WO2000001726A1 (en) | 1998-06-30 | 1999-06-29 | Compounds with growth hormone releasing properties |
Publications (2)
Publication Number | Publication Date |
---|---|
BR9911756A true BR9911756A (pt) | 2001-04-03 |
BRPI9911756B1 BRPI9911756B1 (pt) | 2016-06-14 |
Family
ID=26064788
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI9911756A BRPI9911756B1 (pt) | 1998-06-30 | 1999-06-29 | composto, uso do mesmo, e composição farmaceutica |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP1100824B1 (pt) |
JP (1) | JP4511040B2 (pt) |
KR (1) | KR100907638B1 (pt) |
CN (1) | CN1304424C (pt) |
AT (1) | ATE500269T1 (pt) |
AU (1) | AU771644B2 (pt) |
BR (1) | BRPI9911756B1 (pt) |
CA (1) | CA2334315C (pt) |
CY (1) | CY1111509T1 (pt) |
CZ (1) | CZ299648B6 (pt) |
DE (1) | DE69943239D1 (pt) |
DK (1) | DK1100824T3 (pt) |
HU (1) | HUP0102460A3 (pt) |
IL (1) | IL140044A0 (pt) |
NO (1) | NO331351B1 (pt) |
PL (1) | PL199853B1 (pt) |
PT (1) | PT1100824E (pt) |
RU (1) | RU2298547C2 (pt) |
TW (1) | TW593337B (pt) |
WO (1) | WO2000001726A1 (pt) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002331064B2 (en) * | 2001-08-10 | 2007-08-23 | Palatin Technologies, Inc. | Peptidomimetics of biologically active metallopeptides |
US7476653B2 (en) | 2003-06-18 | 2009-01-13 | Tranzyme Pharma, Inc. | Macrocyclic modulators of the ghrelin receptor |
JP2007531769A (ja) * | 2004-03-30 | 2007-11-08 | サファイア セラピューティクス インコーポレイテッド | 成長ホルモン分泌促進薬を使用したc−反応性蛋白質の低減方法 |
PT1789067E (pt) | 2004-08-12 | 2012-08-06 | Helsinn Healthcare Sa | Utilização de hormona do crescimento secretagogo para a estimulação da motilidade do sistema gastrointestinal |
EP1883627B1 (en) | 2005-05-18 | 2018-04-18 | Pharmascience Inc. | Bir domain binding compounds |
BRPI0617751A2 (pt) | 2005-10-25 | 2011-08-02 | Aegera Therapeutics Inc | compostos de ligação do domìnio iap bir |
CU23558A1 (es) | 2006-02-28 | 2010-07-20 | Ct Ingenieria Genetica Biotech | Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento |
BRPI0807046A2 (pt) | 2007-02-09 | 2015-05-26 | Tranzyme Pharma Inc | Composto, composição farmacêutica, métodos de tratar um distúrbio, uma doença cardiovascular e um paciente que sofre de motilidade gastrointestinal reduzida ou disfuncional e, kit. |
CN107382827B (zh) * | 2017-04-14 | 2021-01-01 | 江苏普莱医药生物技术有限公司 | 氨基酸衍生物或其药学上可接受的盐及应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2168512C2 (ru) * | 1992-12-11 | 2001-06-10 | Мерк Энд Ко., Инк. | Спиропиперидины, способы их получения (варианты) |
HUP9802821A3 (en) * | 1995-06-22 | 2000-03-28 | Novo Nordisk As | Compounds with growth hormone releasing properties |
PL327227A1 (en) * | 1995-12-22 | 1998-12-07 | Novo Nordisk As | Compounds exhibiting growth hormone liberating properties |
AU3434697A (en) * | 1996-07-22 | 1998-02-10 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
AU7906998A (en) * | 1997-06-20 | 1999-01-04 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
-
1999
- 1999-06-29 IL IL14004499A patent/IL140044A0/xx not_active IP Right Cessation
- 1999-06-29 WO PCT/DK1999/000368 patent/WO2000001726A1/en active IP Right Grant
- 1999-06-29 EP EP99929114A patent/EP1100824B1/en not_active Expired - Lifetime
- 1999-06-29 AT AT99929114T patent/ATE500269T1/de active
- 1999-06-29 CN CNB998080861A patent/CN1304424C/zh not_active Expired - Fee Related
- 1999-06-29 BR BRPI9911756A patent/BRPI9911756B1/pt not_active IP Right Cessation
- 1999-06-29 AU AU46038/99A patent/AU771644B2/en not_active Ceased
- 1999-06-29 CZ CZ20004565A patent/CZ299648B6/cs not_active IP Right Cessation
- 1999-06-29 HU HU0102460A patent/HUP0102460A3/hu unknown
- 1999-06-29 PT PT99929114T patent/PT1100824E/pt unknown
- 1999-06-29 RU RU2001102617/04A patent/RU2298547C2/ru active
- 1999-06-29 JP JP2000558127A patent/JP4511040B2/ja not_active Expired - Lifetime
- 1999-06-29 DK DK99929114.9T patent/DK1100824T3/da active
- 1999-06-29 PL PL345204A patent/PL199853B1/pl unknown
- 1999-06-29 KR KR1020007015040A patent/KR100907638B1/ko not_active IP Right Cessation
- 1999-06-29 DE DE69943239T patent/DE69943239D1/de not_active Expired - Lifetime
- 1999-06-29 CA CA2334315A patent/CA2334315C/en not_active Expired - Lifetime
- 1999-08-18 TW TW088114089A patent/TW593337B/zh not_active IP Right Cessation
-
2000
- 2000-12-29 NO NO20006699A patent/NO331351B1/no not_active IP Right Cessation
-
2011
- 2011-06-01 CY CY20111100528T patent/CY1111509T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
NO331351B1 (no) | 2011-12-05 |
ATE500269T1 (de) | 2011-03-15 |
CA2334315C (en) | 2011-07-26 |
NO20006699D0 (no) | 2000-12-29 |
NO20006699L (no) | 2001-02-28 |
DE69943239D1 (de) | 2011-04-14 |
JP4511040B2 (ja) | 2010-07-28 |
PT1100824E (pt) | 2011-06-16 |
KR100907638B1 (ko) | 2009-07-14 |
WO2000001726A1 (en) | 2000-01-13 |
AU771644B2 (en) | 2004-04-01 |
KR20010053310A (ko) | 2001-06-25 |
PL199853B1 (pl) | 2008-11-28 |
CA2334315A1 (en) | 2000-01-13 |
CZ20004565A3 (en) | 2001-06-13 |
EP1100824B1 (en) | 2011-03-02 |
PL345204A1 (en) | 2001-12-03 |
TW593337B (en) | 2004-06-21 |
JP2002519436A (ja) | 2002-07-02 |
CZ299648B6 (cs) | 2008-10-01 |
BRPI9911756B1 (pt) | 2016-06-14 |
CN1304424C (zh) | 2007-03-14 |
DK1100824T3 (da) | 2011-06-20 |
AU4603899A (en) | 2000-01-24 |
CY1111509T1 (el) | 2015-08-05 |
EP1100824A1 (en) | 2001-05-23 |
HUP0102460A3 (en) | 2001-12-28 |
IL140044A0 (en) | 2002-02-10 |
CN1307588A (zh) | 2001-08-08 |
HUP0102460A2 (hu) | 2001-11-28 |
RU2298547C2 (ru) | 2007-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9510168A (pt) | Composto poliaminoácido composição forma unitária de dosagem e método par epreparar uma composição | |
BR9711805A (pt) | Compostos e métodos para providenciar preparações farmacologicamente ativas e uso dos mesmos | |
BRPI0108977B8 (pt) | compostos azacíclicos, composição farmacêutica e uso de um composto ou sal farmaceuticamente aceitável do mesmo | |
HUP9901246A2 (hu) | Növekedési hormon kiválasztását elősegítő vegyületek | |
NO20022264L (no) | Farmasoytisk blanding inneholdende tolterodin, samt anvendelse derav | |
IT1252868B (it) | Composizione farmaceutica anticefalalgica per somministrazione endonasale, procedimento per prepararla e suo impiego terapeutico | |
BR0309875A (pt) | métodos e composições para tratamento de distúrbios do sistema nervoso periférico e novos compostos úteis para isto | |
KR930003912A (ko) | 울혈성 심장 마비 치료법 | |
BR0316305A (pt) | Composto ou um sal farmaceuticamente aceitável do mesmo, métodos para tratar a dor em um animal, para estimular a função do receptor opióide em uma célula, para preparar uma composição, e para tratar diarréia em um animal, composição, e kit | |
BR9709062A (pt) | Composto, composição farmacêutica, e, uso de um composto. | |
BR9507073A (pt) | Composto processos para preparar o mesmo e para tratar uma doença no sistema nervoso central composiçao farmacêutica e uso do composto | |
BR9610480A (pt) | Inibição do fator alfa de necrose tumoral | |
EP0911331A3 (en) | Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use | |
BR9910329A (pt) | Composto, composição farmacêutica, processo para estimular a liberação do hormÈnio de crescimento da pituitária de um mamìfero, e, uso de um composto | |
AU2284001A (en) | Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormone | |
BR9911756A (pt) | Composto, uso de um secretagogo do hormÈnio do crescimento ou um seu sal farmaceuticamente aceitável, composição farmacêutica, método para estimular a liberação do hormÈnio do crescimento pela pituitária de um mamìfero, e, uso de um composto | |
ATE269865T1 (de) | Pyrazolo(3,4-g)chinoxaline als pdgf-rezeptor protein tyrosin-kinase inhibitoren | |
BR9915390A (pt) | Tratamento de tumores através de administração de compostos que liberam harmÈnio de crescimento e seus antagonistas | |
BR9708854A (pt) | Composto composição farmacêutica processo para estimular a liberação do hormônio do crescimento pela pituitária e para aumentar a taxa e grau de crescimento de animais e uso de um composto | |
EG19302A (en) | Compound with gastric acid inhibitory effect and process for its preparation | |
ES2111352T3 (es) | Uso de diester fosfato para el tratamiento de enfermedades retinianas. | |
BR9906975A (pt) | Composto, uso do mesmo, composição farmacêutica, e, processo para estimular a liberação do hormÈnio do crescimento pela pituitária de um mamìfero | |
DK527186D0 (da) | Bronchodilaterende farmaceutisk praeparat | |
BR9915009A (pt) | Composto, composição farmacêutica, método de estimular a liberação do hormÈnio do crescimento da pituitária de um mamìfero, e, uso de um composto ou de um sal farmaceuticamente aceitável do mesmo | |
YU60199A (sh) | Nove soli bpc peptida sa organo-zaštitnom aktivnošću, postupak za njihovo dobijanje i njihova primena u terapiji |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5A ANUIDADE. |
|
B08G | Application fees: restoration [chapter 8.7 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B25A | Requested transfer of rights approved |
Owner name: HELSINN HEALTHCARE SA (CH) |
|
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 14/06/2016, OBSERVADAS AS CONDICOES LEGAIS. |
|
B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 21A ANUIDADE. |
|
B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2594 DE 24-09-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |